Dr Reddy’s Laboratories, a second largest Indian pharma company, has launched sildenafil tablets (20 mg), a bioequivalent generic version of Revatio tablets in the US market on November 16, 2012, following the approval by the United States Food & Drug Administration (US FDA) of Dr. Reddy’s ANDA for sildenafil tablets.
The company said that its sildenafil tablets in 20 mg are available in 90 count bottle sizes.
The Revatio brand had US sales of approximately $338.67 million for the most recent twelve months ending September 2012 according to IMS Health.
Alcon Laboratories Pvt. Ltd. (Novartis India)